Pablo Ryan

6.5k total citations
104 papers, 1.1k citations indexed

About

Pablo Ryan is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Pablo Ryan has authored 104 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Epidemiology, 44 papers in Infectious Diseases and 44 papers in Hepatology. Recurrent topics in Pablo Ryan's work include Hepatitis C virus research (44 papers), Liver Disease Diagnosis and Treatment (23 papers) and Hepatitis B Virus Studies (21 papers). Pablo Ryan is often cited by papers focused on Hepatitis C virus research (44 papers), Liver Disease Diagnosis and Treatment (23 papers) and Hepatitis B Virus Studies (21 papers). Pablo Ryan collaborates with scholars based in Spain, United States and Denmark. Pablo Ryan's co-authors include Jesús Troya, Salvador Resino, Jorge Valencia, Guillermo Cuevas, María Ángeles Jiménez‐Sousa, Juan Torres‐Macho, Sonia Vázquez‐Morón, Alejandro Álvaro‐Meca, José M. Bellón and Amanda Fernández‐Rodríguez and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Pablo Ryan

95 papers receiving 1.1k citations

Peers

Countries citing papers authored by Pablo Ryan

Since Specialization

Citations

This map shows the geographic impact of Pablo Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Ryan more than expected).

Fields of papers citing papers by Pablo Ryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Ryan. The network helps show where Pablo Ryan may publish in the future.

Co-authorship network of co-authors of Pablo Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Ryan. A scholar is included among the top collaborators of Pablo Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Ryan. Pablo Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drug Addiction in Gay and Bisexual Men Living with HIV Engaged in Sexualized Drug Use: Recent Drug Use, Polydrug and Depressive Symptoms as Predictors 2025 ·AIDS and Behavior ·(unknown), Pablo Ryan, Helen Dolengevich-Segal, (unknown), (unknown), Alfonso Cabello, Matilde Sánchez‐Conde, Noemí Cabello‐Clotet, José Sanz, Lucio García‐Fraile, Leire Pérez‐Latorre, Otilia Bisbal, Sara de la Fuente, Juan Emilio Losa, (unknown)	2
2	Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study 2025 ·Non-coding RNA Research ·(unknown), (unknown), Pablo Ryan, Lourdes Domínguez, Luz Martı́n-Carbonero, Ignacio de los Santos, Elena De Matteo, Beatriz Ameigeiras, (unknown), Verónica Briz, María Victoria Preciado, Amanda Fernández‐Rodríguez, Pamela Valva	0
3	Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study 2024 ·BMC Public Health ·(unknown), Luís Morano, Jordi Navarro, Rafael Granados, Josep M. Llibre, Pablo Ryan, Teresa Aldámiz‐Echevarría, Luz Martı́n-Carbonero, Marc Puigvehí, Imma Clotet‐Codina, (unknown), (unknown), (unknown), Juan Berenguer, Javier Crespo, Carlos Roncero	1
4	Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study 2024 ·Journal of Medical Virology ·César Fernández‐de‐las‐Peñas, Juan Torres‐Macho, María Ruiz‐Ruigómez, (unknown), (unknown), (unknown), (unknown), Pablo Ryan, Carlos Lumbreras, Óscar J. Pellicer-Valero, Rocco Giordano, Lars Arendt‐Nielsen, Anabel Franco‐Moreno	5
5	Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors 2024 ·Viruses ·César Fernández‐de‐las‐Peñas, Gema Dı́az-Gil, (unknown), (unknown), Silvia Ambite‐Quesada, Juan Torres‐Macho, Pablo Ryan, Anabel Franco‐Moreno, Óscar J. Pellicer-Valero, Lars Arendt‐Nielsen, Rocco Giordano	3
6	DNA Methylation Levels of the ACE2 Promoter Are Not Associated with Post-COVID-19 Symptoms in Individuals Who Had Been Hospitalized Due to COVID-19 2024 ·Microorganisms ·César Fernández‐de‐las‐Peñas, Gema Dı́az-Gil, (unknown), (unknown), Silvia Ambite‐Quesada, Juan Torres‐Macho, Pablo Ryan, Anabel Franco‐Moreno, Óscar J. Pellicer-Valero, Lars Arendt‐Nielsen, Rocco Giordano	0
7	Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk 2023 ·Immunity & Ageing ·Rubén Martín‐Escolano, (unknown), Javier Crespo, Pablo Ryan, Luís Miguel Real, (unknown), Joaquín Cabezas, Juan Macı́as, M. Arias, Guillermo Cuevas, Ana Virseda‐Berdices, Verónica Briz, Salvador Resino, María Ángeles Jiménez‐Sousa, Amanda Fernández‐Rodríguez	4
8	Recently acquired hepatitis C: Epidemiological characteristics and treatment response in a large cohort of MSM living with HIV in Madrid 2023 ·Enfermedades Infecciosas y Microbiología Clínica ·Luz Martı́n-Carbonero, Ángela Gutiérrez, Otilia Bisbal, Jorge Vergas, (unknown), (unknown), María Jesús Vivancos, José Sanz, Beatriz Álvarez, (unknown), Ignacio de los Santos, Daniel Sepúlveda‐Crespo, Salvador Resino, Juan Berenguer, (unknown), Juan González‐García, Pablo Ryan	0
9	Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain 2023 ·SHILAP Revista de lepidopterología ·Jeffrey V. Lazarus, Marcela Villota‐Rivas, Pablo Ryan, Marı́a Buti, Lara Grau‐López, Guillermo Cuevas, (unknown), (unknown), Raúl Felipe Palma-Álvarez, Jordan J. Feld, (unknown)	5
10	Relative telomere length impact on mortality of COVID‐19: Sex differences 2022 ·Journal of Medical Virology ·Ana Virseda‐Berdices, (unknown), Óscar Martínez-Nieto, Rafael Blancas, Salvador Resino, Pablo Ryan, María Martin‐Vicente, Oscar Brochado‐Kith, Natalia Blanca‐López, (unknown), Blanca López Matamala, C. Martín Parra, María Ángeles Jiménez‐Sousa, Amanda Fernández‐Rodríguez	4
11	Plasma miRNA profile at COVID-19 onset predicts severity status and mortality 2022 ·Emerging Microbes & Infections ·(unknown), Ana Virseda‐Berdices, Salvador Resino, Pablo Ryan, Óscar Martínez-Nieto, Felipe Pérez‐García, María Martin‐Vicente, (unknown), Oscar Brochado‐Kith, Rafael Blancas, (unknown), Francisco C. Ceballos, (unknown), (unknown), David Alonso, Natalia Blanca‐López, (unknown), Laura Martín‐Pedraza, María Ángeles Jiménez‐Sousa, Amanda Fernández‐Rodríguez	56
12	Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study 2022 ·Journal of Clinical Medicine ·(unknown), (unknown), Santiago Moreno, Noemí Cabello, Pablo Ryan, (unknown), Otilia Bisbal, María Jesús Vivancos, Marı́a José Núñez, Jesús Troya, (unknown), Julián Olalla	2
13	HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study 2021 ·International Journal of Drug Policy ·Pablo Ryan, Jorge Valencia, Guillermo Cuevas, Jesús Troya, (unknown), Antonio Rodríguez, Juan Torres‐Macho, (unknown), (unknown), Sonia Vázquez‐Morón, Salvador Resino	16
14	Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain 2021 ·Journal of Clinical Immunology ·Jesús Troya, Paul Bastard, Laura Planas‐Serra, Pablo Ryan, Montserrat Ruíz, (unknown), Juan Torres‐Macho, (unknown), Laurent Abel, Jean‐Laurent Casanova, Aurora Pujol	71
15	Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐care 2021 ·Liver International ·Jorge Valencia, Jeffrey V. Lazarus, Francisco C. Ceballos, Jesús Troya, Guillermo Cuevas, Salvador Resino, Juan Torres‐Macho, Pablo Ryan	11
16	The PANDEMYC Score. An Easily Applicable and Interpretable Model for Predicting Mortality Associated With COVID-19 2020 ·Journal of Clinical Medicine ·Juan Torres‐Macho, Pablo Ryan, Jorge Valencia, Mario Pérez, Eva Jiménez, Mario Fontán‐Vela, Elsa Izquierdo-García, (unknown), (unknown), (unknown), (unknown), (unknown), Salvador Resino, (unknown), Alejandro Álvaro‐Meca	32
17	COVID‐19 in patients with hematological malignancies: A retrospective case series 2020 ·International Journal of Laboratory Hematology ·(unknown), Isabel González-Gascón-y-Marín, (unknown), (unknown), María Ángeles Foncillas, (unknown), (unknown), Pablo Ryan, José‐Ángel Hernández‐Rivas	16
18	Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study 2020 ·BMJ Open ·Eva Jiménez, Mario Fontán‐Vela, Jorge Valencia, (unknown), (unknown), Elsa Izquierdo-García, (unknown), (unknown), Jesús Troya, (unknown), (unknown), (unknown), Ane Abad‐Motos, (unknown), Pablo Ryan, Mario Pérez	43
19	Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study 2018 ·PLoS ONE ·Jesús Troya, Rocío Montejano, Pablo Ryan, (unknown), Mariano Matarranz, Alfonso Cabello, Francisco Vera‐Sempere, (unknown), Ignacio de los Santos, Gloria Sampériz, P Bachiller, Vicente Boix, Pilar Barrufet, Miguel Cervero, José Sanz, (unknown), María Yllescas, Eulalia Valencia, (unknown)	2
20	Evaluation of dried blood spot samples for screening of hepatitis C and human immunodeficiency virus in a real-world setting 2018 ·Scientific Reports ·Sonia Vázquez‐Morón, Pablo Ryan, (unknown), Dolores Martín, Jesús Troya, Guillermo Cuevas, Jorge Valencia, María Ángeles Jiménez‐Sousa, Ana Avellón, Salvador Resino	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact